Enabling low- and middle-income countries to strengthen their pharmaceutical systems to ensure sustainable access to and appropriate use of essential medicines and related pharmaceutical services.
The Program Has Five Main Objectives
Improving pharmaceutical services, including product availability and patient-centered care, to achieve health outcomes
Optimizing pharmaceutical-sector financing, including resource allocation and use
Increasing the availability and use of pharmaceutical information for decision making and advancing the global learning agenda
Increasing institutional and human resource capacity for pharmaceutical management and services, including regulation of medical products
Strengthening pharmaceutical-sector governance
What's Happening at MTaPS
By Jane Briggs, Senior Principal Technical Advisor and MNCH Lead, MTaPS
Equipping Health Workers with Treatment Protocols and Job Aids to Reduce Maternal and Child Mortality in DRC
A significant proportion of maternal and child deaths can be avoided if women and children have access to quality, adequate health services and if the necessary quality medical products, supplies, and skilled health providers are available.
Antibiotics are essential for both human and animal health. The symbiotic relationship among humans, animals, and the environment requires a multisectoral, transdisciplinary approach to control the growing crisis of antimicrobial resistance (AMR)—an approach that is enshrined in One Health.